Regeneron Pharmaceuticals Book Value Per Share

REGN -- USA Stock  

Quarterly Earning Report: November 5, 2019  

Regeneron Pharmaceuticals book-value-per-share fundamental analysis lookup allows you to check this and other indicators for Regeneron Pharmaceuticals or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Regeneron Pharmaceuticals Book Value Per Share Analysis

Book Value per Share (B/S) is can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing effects of liabilities. In other words a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of liquidation.
Book Value per Share 
Common Equity 
Average Shares 
More About Book Value Per Share | All Equity Analysis
Regeneron Pharmaceuticals Book Value Per Share  =
Regeneron Pharmaceuticals ValuationFundamentalsBuy or Sell

Regeneron Pharmaceuticals Book Value Per Share Over Time Pattern

 Regeneron Pharmaceuticals Book Value per Share 

About Book Value Per Share

The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as good will, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Compare to competition

Regeneron Pharmaceuticals Book Value Per Share Assessment

Shareholders Equity
In accordance with recently published financial statements the book value per share of Regeneron Pharmaceuticals is about 89 times. This is 5350.0% lower than that of the Healthcare sector, and 135.9% lower than that of Biotechnology industry, The Book Value Per Share for all stocks is 95.38% higher than the company.

Regeneron Pharmaceuticals Book Value Per Share Peer Comparison

  Book Value Per Share 
      Regeneron Pharmaceuticals Comparables 
Regeneron Pharmaceuticals is rated second in book value per share category among related companies.

Regeneron Pharmaceuticals current financial ratios